Monitor the company's progress toward the $1 billion run-rate target, particularly the successful deployment and commissioning of infrastructure capacity. The sale of Ekso Bionics removes a non-core distraction, but capital access and equipment availability remain key risks.
Price Chart
Executive Summary
ChronoScale announced a contract extension with an existing AI infrastructure customer and a new customer agreement, projecting an annualized revenue run rate of $1 billion by calendar Q3 2027. The company also completed the sale of its Ekso Bionics business unit to focus on core AI infrastructure. These developments signal strong customer demand and strategic refocusing, but the revenue target is forward-looking and subject to execution risks.
Key Facts
- Signed a contract extension with an existing AI infrastructure customer and an agreement with a new AI infrastructure customer.
- Together with existing contracts, these agreements provide for annualized run-rate revenue of $1 billion by calendar Q3 2027.
- Completed the sale of the Ekso Bionics business unit to focus on core accelerated compute and AI infrastructure.
- The company operates as an independent public company focused on scalable GPU-based infrastructure for AI training, inference, and HPC.
Financial Impact
Projected annualized revenue run rate of $1 billion by Q3 2027, up from an undisclosed current base. Sale of Ekso Bionics unit completed, amount not disclosed.
Risk Factors
- Achievement of $1 billion run-rate revenue is subject to successful and timely deployment of infrastructure, availability of power and equipment, and access to capital on acceptable terms.
- Customer concentration and ability to renew or expand customer relationships.
- Forward-looking statements are inherently uncertain; actual results may differ materially.
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3373455 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 11d ago | DEFA14A | $14.97 $15.76 | ▲ +5.28% | ▲ +4.94% | $17.49 (+16.83%) |
Oct 15, 2026 12d ago | 8-K | $15.08 $14.97 | ▼ −0.73% | ▼ −1.15% | $17.49 (+15.98%) |
Oct 15, 2026 12d ago | Press Release | $15.08 $14.97 | ▼ −0.73% | ▼ −1.15% | $17.49 (+15.98%) |
Oct 13, 2026 14d ago | EFFECT | $16.31 $14.88 | ▲ +8.77% | ▲ +7.69% | $17.49 (−7.23%) |
Oct 6, 2026 21d ago | 8-K | $19.77 $19.03 | ▼ −3.74% | ▼ −3.32% | $17.49 (−11.53%) |
Oct 6, 2026 21d ago | S-3 | $19.77 $19.03 | ▼ −3.74% | ▼ −3.32% | $17.49 (−11.53%) |
Oct 2, 2026 25d ago | 8-K | $18.60 $19.28 | ▲ +3.66% | ▲ +3.11% | $17.49 (−5.97%) |
Oct 1, 2026 26d ago | Press Release | $19.21 $18.60 | ▼ −3.18% | ▼ −3.85% | $17.49 (−8.95%) |
Sep 25, 2026 4w ago | DEFA14A | $19.82 $19.75 | ▼ −0.33% | ▼ −0.14% | $17.49 (−11.73%) |
Sep 25, 2026 4w ago | DEF 14A | $19.82 $19.75 | ▼ −0.33% | ▼ −0.14% | $17.49 (−11.73%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers